Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Malignant Lymphoma

Free Subscription Articles published in Br J Dermatol Retrieve available abstracts of 42 articles: HTML format

Single Articles

July 2026
1. 
   Correction to: LY21 A rare case of cutaneous CD4-positive cytotoxic T-cell lymphoma.
   Br J Dermatol. 2026 Jul 29:ljag304. doi: 10.1093.
   PubMed    
   
   
   
2. MURAT DE MONTAI Q, Bourrat E, Battesti G, Hickman G, et al
   Cutaneous T-cell lymphoma in the setting of NIPAL4-related nonsyndromic epidermal differentiation disorder: three cases.
   Br J Dermatol. 2026 Jul 22:ljag302. doi: 10.1093.
   PubMed    
   
   
   April 2026
3. KHOSHNIYATI S, Fleischli A, Niknejad K, Weiner J, et al
   The prognostic impact of prior atopic dermatitis on cutaneous T-cell lymphoma: a single-center retrospective cohort study.
   Br J Dermatol. 2026 Apr 16:ljag143. doi: 10.1093.
   PubMed    
   
   
   December 2025
4. RAMWANI M, Solman L
   P13 The cellulitis that wasn't: a case of subcutaneous panniculitis-like T-cell lymphoma in a toddler.
   Br J Dermatol. 2025;193.
   PubMed     Abstract available
   
   
   
5. GAN X, Wu Y, Sun X, Zhao A, et al
   Chimeric antigen receptor T-cell therapy for relapsed/refractory primary cutaneous B-lymphoblastic lymphoma with rapid and durable systemic regression.
   Br J Dermatol. 2025 Dec 2:ljaf484. doi: 10.1093.
   PubMed    
   
   
   November 2025
6. CHEN J, Francis P, Martinez A, Marre E, et al
   Exploring sexual health in patients with cutaneous T-cell lymphoma: a mixed methods study.
   Br J Dermatol. 2025 Nov 20:ljaf466. doi: 10.1093.
   PubMed    
   
   
   
7. LISLE TL, Weis-Banke SE, Ahmad SM, Holmstrom MO, et al
   Harnessing Arginase-2-specific CD8+ T cells to target immunosuppressive Cutaneous T cell Lymphoma.
   Br J Dermatol. 2025 Nov 10:ljaf450. doi: 10.1093.
   PubMed     Abstract available
   
   
   September 2025
8. HODAK E, Amitay-Laish I, Bagot M, Battistella M, et al
   ISCL/EORTC-CLTG/USCLC recommendations for the diagnosis, staging and treatment of early-stage paediatric mycosis fungoides: a modified Delphi consensus. Part two: treatment.
   Br J Dermatol. 2025;193:653-661.
   PubMed     Abstract available
   
   
   
9. GHOSH S, Pavlova O, Latshaw A, Kim D, et al
   Multi-Harmonic Imaging-Based Automated Recognition of Cutaneous T-Cell Lymphoma.
   Br J Dermatol. 2025 Sep 4:ljaf345. doi: 10.1093.
   PubMed     Abstract available
   
   
   August 2025
10. HODAK E, Amitay-Laish I, Bagot M, Battistella M, et al
    ISCL/EORTC-CLTG/USCLC recommendations for the diagnosis, staging and treatment of early-stage paediatric mycosis fungoides: a modified Delphi consensus. Part one: diagnosis and staging.
    Br J Dermatol. 2025;193:405-414.
    PubMed     Abstract available
    
    
    
11. WILLEMZE R, Assaf C, Bagot M, Beylot-Barry M, et al
    EORTC/USCLC/ISCL consensus recommendations for management and treatment of cutaneous lymphoproliferative disorders.
    Br J Dermatol. 2025 Aug 6:ljaf312. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2025
12. IVERT LU, Ekberg S, Smedby KE, Brauner H, et al
    Increased mortality due to lymphoma and infections in patients with mycosis fungoides or Sezary syndrome: A Swedish nationwide, population-based cohort study.
    Br J Dermatol. 2025 Jun 19:ljaf233. doi: 10.1093.
    PubMed    
    
    
    
13. LIU Z, Zhang Y, Wang K, Xie F, et al
    Early diagnosis model of mycosis fungoides and five inflammatory skin diseases based on multi-modal data-based convolutional neural network.
    Br J Dermatol. 2025 Jun 4:ljaf212. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2025
14. DOELEMAN T, Beljaards ESM, Ottevanger R, Jansen P, et al
    Added value of pathology consultations in cutaneous lymphomas: a 2-year review from the Dutch national referral and expertise centre.
    Br J Dermatol. 2025 May 14:ljaf184. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2025
15. PILERI A, Zengarini C
    Harnessing Extracorporeal Photopheresis to Trigger Immunogen Cell Death: A Bounty on Cutaneous Lymphoma Cells.
    Br J Dermatol. 2025 Apr 12:ljaf138. doi: 10.1093.
    PubMed    
    
    
    March 2025
16. BAGOT M
    Therapeutic advances for Cutaneous T Cell Lymphoma.
    Br J Dermatol. 2025 Mar 22:ljaf105. doi: 10.1093.
    PubMed     Abstract available
    
    
    
17. LACKNER A, Burner T, Brandner M, Dey S, et al
    Evidence of Immunogenic Cell Death (ICD) and ICD-dependent Dendritic Cell Activation Induced by Extracorporeal Photopheresis in Patients with leukemic forms of cutaneous T cell lymphoma.
    Br J Dermatol. 2025 Mar 20:ljaf102. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2025
18. COSTANZA M, Giordano C, von Brunneck AC, Zhao J, et al
    Preclinical in vitro and in vivo evidence for CD74-targeting as effective treatment strategy for cutaneous T cell lymphomas.
    Br J Dermatol. 2025 Feb 27:ljaf001. doi: 10.1093.
    PubMed     Abstract available
    
    
    
19. OTTEVANGER R, Vermeer MH
    Cutaneous T-cell lymphoma in Australia: what drives geospatial?
    Br J Dermatol. 2025 Feb 22:ljaf026. doi: 10.1093.
    PubMed    
    
    
    
20. GNIADECKI R, Guenova E, Querfeld C, Nicolay JP, et al
    Haematogenous seeding in mycosis fungoides and Sezary syndrome: current evidence and clinical implications.
    Br J Dermatol. 2025;192:381-389.
    PubMed     Abstract available
    
    
    
21. WEHKAMP U, Pietzka S, Kotrova M, Jost M, et al
    Mycosis fungoides: differentiation from inflammation and detection of circulating tumour cells with the EuroClonality next-generation sequencing assay.
    Br J Dermatol. 2025;192:492-500.
    PubMed     Abstract available
    
    
    January 2025
22. GNIADECKI R
    Chaperoning a Cure: Unexpected Role of CD74 in Cutaneous T-cell lymphoma.
    Br J Dermatol. 2025 Jan 29:ljaf040. doi: 10.1093.
    PubMed    
    
    
    December 2024
23. BONTOUX C, Badrignans M, Afach S, Sbidian E, et al
    Pustular mycosis fungoides has a poor outcome: a multicentric clinicopathological and molecular case series.
    Br J Dermatol. 2024;192:125-134.
    PubMed     Abstract available
    
    
    
24. CAMPBELL BA, Baade PD, Dasgupta P, Cameron JK, et al
    Geospatial analyses demonstrate variation of cutaneous T-cell lymphomas across Australia, providing insights into possible causes.
    Br J Dermatol. 2024 Dec 6:ljae476. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2024
25. BLANCHARD G, Atallah I, Blanchard M, Fehrenbacher B, et al
    Primary cutaneous T-cell lymphoma not otherwise specified (NOS) uncovering a novel RAB27A variant in Griscelli syndrome type 2.
    Br J Dermatol. 2024 Oct 21:ljae412. doi: 10.1093.
    PubMed    
    
    
    September 2024
26. TENSEN CP, Vermeer MH
    Single cell analyses of cutaneous T-cell lymphoma biopsies.
    Br J Dermatol. 2024 Sep 13:ljae351. doi: 10.1093.
    PubMed    
    
    
    August 2024
27. STADLER R
    The interferon story continues: EORTC CLTG study explores pegylated interferon alpha-2a's role in treating mycosis fungoides/Sezary syndrome.
    Br J Dermatol. 2024;191:321-322.
    PubMed    
    
    
    
28. MITSUNAGA K, Bagot M, Ram-Wolff C, Guenova E, et al
    Real-world study of pegylated interferon alpha-2a to treat mycosis fungoides/Sezary syndrome using time to next treatment as a measure of clinical benefit: an EORTC CLTG study.
    Br J Dermatol. 2024;191:419-427.
    PubMed     Abstract available
    
    
    
29. CHENNAREDDY S, Rindler K, Ruggiero JR, Alkon N, et al
    Single-cell RNA sequencing comparison of CD4+, CD8+ and TCR-gammadelta+ cutaneous T-cell lymphomas reveals subset-specific molecular phenotypes.
    Br J Dermatol. 2024 Aug 12:ljae313. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2024
30. RAYMUNDO C, Cella D, Wagner L, Hippe DS, et al
    Development and psychometric properties of the Functional Assessment of Cancer Therapy-Cutaneous T-Cell Lymphoma (FACT-CTCL).
    Br J Dermatol. 2024 Jul 30:ljae308. doi: 10.1093.
    PubMed     Abstract available
    
    
    
31. BATTISTELLA M
    Paediatric lymphomatoid papulosis: a benign clonal T-cell disorder that is a harbinger of haematological malignancy.
    Br J Dermatol. 2024;191:158-159.
    PubMed    
    
    
    June 2024
32. WOBSE M, Appenzeller S, Roth S, Siedel C, et al
    Oncogenic alterations in KIR3DL1 in cutaneous acral CD8+ lymphoproliferative disorder.
    Br J Dermatol. 2024 Jun 27:ljae256. doi: 10.1093.
    PubMed     Abstract available
    
    
    
33. TZOUMPA S, Ingen-Housz-Oro S, de Masson A, Pham-Ledard A, et al
    Evolution of patients with Sezary syndrome after mogamulizumab discontinuation for any cause except progression: a multicentre retrospective study (Moga-stop Study).
    Br J Dermatol. 2024;191:143-144.
    PubMed    
    
    
    May 2024
34. JAMES M, Nakamura M, Whittaker S, Morris S, et al
    Mycosis fungoides: successful re-treatment with brentuximab vedotin.
    Br J Dermatol. 2024;190:929-930.
    PubMed    
    
    
    
35. RODRIGUEZ M, Rebollo-Gonzalez M, Frutos Diaz-Alejo J, Manso R, et al
    Mutational profiling of Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorders do not resemble nodal peripheral T-cell lymphomas with follicular helper T-cell phenotype.
    Br J Dermatol. 2024 May 13:ljae192. doi: 10.1093.
    PubMed    
    
    
    April 2024
36. BLANCHARD M, Morren MA, Busschots AM, Hauben E, et al
    Paediatric onset lymphomatoid papulosis: results of a multicentre retrospective cohort study, on behalf of the EORTC Cutaneous Lymphoma Tumours Group (CLTG).
    Br J Dermatol. 2024 Apr 10:ljae150. doi: 10.1093.
    PubMed     Abstract available
    
    
    
37. ROCCUZZO G, Calvao J, Dobos G, Morsia E, et al
    Cutaneous T-cell lymphoma care across Europe: insights from the Horizon Project.
    Br J Dermatol. 2024 Apr 5:ljae145. doi: 10.1093.
    PubMed    
    
    
    February 2024
38. STAMMLER R, Ta VA, Cohen E, Ram-Wolff C, et al
    Failure of second challenge with Mogamulizumab in CCR4-positive cutaneous T-cell lymphoma.
    Br J Dermatol. 2024 Feb 23:ljae085. doi: 10.1093.
    PubMed    
    
    
    
39. JUNG JM, Cho HS, Kim GH, Won CH, et al
    Psoriasiform mycosis fungoides: a clinical and prognostic retrospective cohort study.
    Br J Dermatol. 2024;190:432-434.
    PubMed    
    
    
    January 2024
40. TRUM NA, Chen L, Zain J, Rosen ST, et al
    Significant survival disparity in Black patients with cutaneous lymphoma: a retrospective cohort study.
    Br J Dermatol. 2024 Jan 29:ljae039. doi: 10.1093.
    PubMed    
    
    
    October 2023
41. 
    Multiple skin lesions, especially on the legs, predict a poorer prognosis in skin lymphoma with large tumour cells.
    Br J Dermatol. 2023;189:e98.
    PubMed    
    
    
    
42. 
    The effect of extracorporeal photopheresis on cytokines released by leukaemic cutaneous T-cell lymphoma.
    Br J Dermatol. 2023;189:e97.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum